CellaVision AB engages in the provision of digital microscopy solutions for hematology laboratories. The company is headquartered in Lund, Skane and currently employs 228 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Follow-Up Questions
CLVSF 주식의 가격 성능은 어떻습니까?
CLVSF의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
CellaVision AB의 주요 사업 주제나 업종은 무엇입니까?
CellaVision AB은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
CellaVision AB의 시가총액은 얼마입니까?
CellaVision AB의 현재 시가총액은 $0입니다
CellaVision AB는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 5명의 분석가가 CellaVision AB에 대한 분석 평가를 실시했으며, 이는 2명의 강력한 매수, 5명의 매수, 1명의 보유, 0명의 매도, 그리고 2명의 강력한 매도를 포함합니다
